Skip to main content

2025 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Kazunobu Moriguchi

Director of Analytical Development
Takeda Pharmaceutical Company Limited

Poster(s):

(M1230-05-31) Physiologically Based Biopharmaceutics Modeling of Formulation Bioequivalence for Mobocertinib, a Weak Base, Using pH-Dependent Dissolution Data

Monday, November 10, 2025
12:30 PM - 1:30 PM CT